Welgus Howard G., a director at Arcutis Biotherapeutics, Inc. ($ARQT), sold shares on the open market 14 times over the past year, totaling $2.4 million. His most recent sale occurred on March 2, 2026. These sales rank him 3,116th among 11,678 insiders in our database by total value sold, below the average of $8.6 million per insider and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $23.88 | 39,744.0000 | 132,885,000 | 20.10% | 0.01% |
| March 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $25.65 | 49,744.0000 | 132,885,000 | 16.74% | 0.01% |
| Feb. 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $25.05 | 59,744.0000 | 132,885,000 | 14.34% | 0.01% |
| Jan. 2, 2026 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $28.96 | 69,744.0000 | 132,885,000 | 12.54% | 0.01% |
| Dec. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $30.21 | 79,744.0000 | 132,885,000 | 11.14% | 0.01% |
| Nov. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $25.27 | 89,744.0000 | 132,885,000 | 10.03% | 0.01% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 9538 | $0.00 | 0.0000 | 132,885,000 | 100.00% | 0.01% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 462 | $18.92 | 99,744.0000 | 132,885,000 | 0.46% | 0.00% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 9538 | $18.92 | 100,206.0000 | 132,885,000 | 8.69% | 0.01% |
| Oct. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 9538 | $1.68 | 109,744.0000 | 132,885,000 | 9.52% | 0.01% |
| Sept. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $15.64 | 100,206.0000 | 120,957,633 | 9.07% | 0.01% |
| Sept. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 10000 | $0.00 | 0.0000 | 120,957,633 | 100.00% | 0.01% |
| Sept. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 10000 | $0.00 | 110,206.0000 | 120,957,633 | 9.98% | 0.01% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 6110 | $0.00 | 0.0000 | 120,957,633 | 100.00% | 0.01% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 3890 | $14.30 | 100,206.0000 | 120,957,633 | 3.74% | 0.00% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 3890 | $0.00 | 104,096.0000 | 120,957,633 | 3.88% | 0.00% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 6110 | $14.30 | 100,206.0000 | 120,957,633 | 5.75% | 0.01% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 6110 | $0.00 | 106,316.0000 | 120,957,633 | 6.10% | 0.01% |
| Aug. 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 3890 | $0.00 | 0.0000 | 120,957,633 | 100.00% | 0.00% |
| July 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 9208 | $13.84 | 100,206.0000 | 120,957,633 | 8.42% | 0.01% |
| June 18, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10139 | $13.37 | 109,414.0000 | 120,957,633 | 8.48% | 0.01% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | A | Common Stock | 7609 | $0.00 | 119,553.0000 | 120,957,633 | 6.80% | 0.01% |
| June 12, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | A | Stock Option (right to buy) | 20568 | $0.00 | 20,568.0000 | 120,957,633 | 9999.99% | 0.02% |
| May 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $14.64 | 111,944.0000 | 120,957,633 | 8.20% | 0.01% |
| April 1, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $15.12 | 121,944.0000 | 120,957,633 | 7.58% | 0.01% |
| March 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $13.00 | 131,944.0000 | 120,957,633 | 7.05% | 0.01% |
| Feb. 3, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $12.71 | 141,944.0000 | 120,957,633 | 6.58% | 0.01% |
| Jan. 2, 2025 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $14.67 | 151,944.0000 | 120,957,633 | 6.17% | 0.01% |
| Dec. 2, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $12.51 | 161,944.0000 | 124,302,317 | 5.82% | 0.01% |
| Nov. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $8.65 | 171,944.0000 | 124,302,317 | 5.50% | 0.01% |
| Oct. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $9.26 | 181,944.0000 | 124,302,317 | 5.21% | 0.01% |
| Sept. 3, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $10.77 | 191,944.0000 | 69,305,487 | 4.95% | 0.01% |
| Aug. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 6614 | $9.87 | 205,330.0000 | 69,305,487 | 3.12% | 0.01% |
| Aug. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 3386 | $9.87 | 201,944.0000 | 69,305,487 | 1.65% | 0.00% |
| Aug. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 6614 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.01% |
| Aug. 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 6614 | $1.68 | 211,944.0000 | 69,305,487 | 3.22% | 0.01% |
| July 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 5681 | $1.68 | 211,011.0000 | 69,305,487 | 2.77% | 0.01% |
| July 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 4319 | $1.68 | 215,330.0000 | 69,305,487 | 2.05% | 0.01% |
| July 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 10000 | $9.31 | 205,330.0000 | 69,305,487 | 4.64% | 0.01% |
| July 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 5681 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.01% |
| July 1, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 4319 | $0.00 | 6,614.0000 | 69,305,487 | 39.50% | 0.01% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | A | Stock Option (right to buy) | 27052 | $0.00 | 27,052.0000 | 69,305,487 | 9999.99% | 0.04% |
| June 14, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | A | Common Stock | 10139 | $0.00 | 205,330.0000 | 69,305,487 | 5.19% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 6458 | $0.00 | 0.0000 | 69,305,487 | 100.00% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 6458 | $1.68 | 205,191.0000 | 69,305,487 | 3.25% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 3542 | $8.00 | 201,649.0000 | 69,305,487 | 1.73% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | S | Common Stock | 6458 | $8.01 | 195,191.0000 | 69,305,487 | 3.20% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Stock Option (right to buy) | 3542 | $0.00 | 5,681.0000 | 69,305,487 | 38.40% | 0.01% |
| June 4, 2024 | Arcutis Biotherapeutics, Inc. | $ARQT | Welgus Howard G. | Director | M | Common Stock | 3542 | $1.68 | 198,733.0000 | 69,305,487 | 1.81% | 0.01% |